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Title: Public Scholarship and the Evidence Movement: Understanding and Learning from Belgian Drug 
Policy Development 
 
Abstract 
Debates about public scholarship have gathered momentum in several fields including sociology and 
criminology. There is much debate over the nature of public scholarship and the forms it can take. In 
criminology one of the most influential analyses of public scholarship has been developed by Loader 
and Sparks. For these two thinkers part of the task of scholarship is to contribute to better ‘politics’. In 
their hands, public criminology is close to another long-running analytical trend; research utilisation. 
The two literatures have for the most part remained separate. This paper puts Loader and Sparks’ 
framework of public scholarship to the empirical test to see if and how it contributes to understanding 
the role and nature of evidence use in highly sensitive policy areas. We do this through an analysis of 
recent changes in Belgian drugs policy. We conclude that the framework of Loader and Sparks, although 
useful in illuminating how publicly engaged scholars can influence and mobilise more open and better 
informed public and political debate, is hamstrung, by its concentration on the action of individuals in 
isolation from the complex power structures that underpin the policy process. Synthesising lessons 
drawn from the research utilisation literature with the work of public criminology provides a potential 
way forward in understand the role of evidence in policy and also producing ‘better’ politics in this 
context. 
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Public Scholarship and the Evidence Movement: Understanding and Learning from Belgian Drug Policy 
Development 
Introduction 
In the run up to the 2016 referendum on whether Britain should remain within or leave the European 
Union, Michael Gove, a then Government Minister and leading campaigner for ‘Leave’, declared with 
some irony that British people no longer trusted and have ‘had enough’ of experts (Menon and Portes, 
2016). The irony concerned the fact Gove had spent the prior months specifically seeking out the views 
of experts on penal reform. This episode was the first indication of a 2016 vintage of ‘post-truth politics’ 
that encompassed not only the UK’s EU referendum, but also the US Presidential Election. In each case, 
the expert was cast as being at best peripheral to public debate and at worse, an irrelevance. Indeed, 
in one statement, Gove dismissed the need for research input into policy development, a topic that has 
been central to two emerging debates across a number of disciplines. The first is the debate that policy 
should be based on evidence or expertise, which has been considered as common sense particularly 
since the ideal of evidence-based policy-making gained significant currency in the 1990s (O’Dwyer, 
2004; Hughes, 2007). The second, and perhaps broader discussion, concerns the long-standing 
discussion of what might collectively be termed ‘public scholarship’ (Foucault, 1972; Barak, 1988; 
Carrier, 2014; Carlen, 2011; Wacquant, 2011). Notable expressions of public scholarship have taken the 
form of recent calls for more ‘public sociology’ (e.g. Burawoy, 2005) and ‘public criminology’ (Loader 
and Sparks, 2011) both of which rest on the principle that academic scholarship must apply beyond the 
academy whether that is through a reconnection with civil society or through more open dialogue 
between academic and policy communities.  
While the evidence-based policy and public scholarship literatures have emerged separately, there is 
great potential for learning across them and both can contribute to what Loader and Sparks (2011) 
refer to as a ‘better politics’ of crime and its regulation. For Loader and Sparks, this is necessary as 
criminal justice policy making takes place in a hostile environment with the difficulties this entails for 
rational debate. Such debates are also typical of drugs policy where evidence is harnessed in support 
or critique of a policy, but often decisions are made with recourse to instinct or ideology (MacGregor, 
2011; 2013; Monaghan, 2011; Stevens, 2011). We contend, however, that by using an empirical 
example of recent Belgian drug policy development we uncover some shortcomings with Loader and 
Sparks (2011) typology, which can be overcome by drawing on lessons from the research 
utilisation/evidence-based policy literature.  
In this article, we document the trajectory of Belgian drugs policy to critically appraise the application 
of public criminology – as comprehensively captured by Loader and Sparks’ (2011) influential analysis. 
In doing so we consider and explain the mechanisms through which scientists engage with policy and 
practice and the roles they take. Whether and how public scholars themselves perceive and handle 
their public engagements in terms of using evidence has been relatively neglected in discussion of 
public scholarship (for an exception, see Drake and Walters, 2015). We conclude that Loader and 
Sparks’ typology is a useful tool for mapping the development of policy, but that its focus on the 
autonomy and capacity of key actors masks the more complex power structures that exist in policy 
development. We suggest that when synthesised with findings from the longer-established research 
utilisation literature, a more complex understanding of the interplay between evidence and policy is 
possible and by association so is a form of ‘better politics’ in drugs policy and criminal justice. In doing 
so, the article is organised in the following way. The next section explores in more detail the rise of 
public criminology illustrating some of its features. We then consider some of the key features of the 
research utilisation literature. We then use these discussions as a platform to discuss the role of 
evidence in our chosen case study. Moving on we offer a critical appraisal of Loader and Sparks’ (2011) 
typology before some summarising remarks.  
 
The Rise of Public Criminology 
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Debates over public sociology have become the reference point for debates in public scholarship more 
generally. It is just over 10 years since Michael Burawoy (2005) proclaimed his manifesto for public 
sociology, drawing on a long tradition stretching back to the very foundation of the discipline of 
sociology as both Marx and Durkheim could be considered as public intellectuals. In criminology, the 
role of, and the relationship between, academic criminology and publics outside of the academy has 
been the subject of much intellectual debate much of which predates Burawoy’s intervention (e.g. 
Foucault, 1972; Barak, 1988; Garland and Sparks, 2000; Carrier, 2014; Carlen, 2011; Wacquant, 2011). 
The concept of public criminology was first coined by Carrabine, Lee and South (2000), but commentary 
on the topic gathered apace around 2007 (e.g. Currie, 2007; Chancer and McLaughlin, 2007). 
Contemporary debates over public criminology are set against the backdrop of an increasing realisation 
that as criminology has flourished in the academy, its influences on policy development as well as on 
public knowledge about realities of crime and justice has floundered (Garland and Sparks, 2000; Tonry, 
2010; Uggen and Inderbitzin, 2010; Loader and Sparks, 2011). In other words, as Daems, (2008; p.241) 
notes, ‘in times as ours when ‘crime talk’ flourishes, its voice seems – somehow, somewhere – to get 
lost’. Loader and Sparks (2011) refer to this as criminology’s ‘successful failure’.  
Discussions over the public function of criminology are varied. For some, the ‘public’ role of scholarship 
involves promoting criminological ideas through mainstream media (e.g. Barak, 2007; Wilson and 
Groombridge, 2010). For others, public scholarship is trying to push the theoretical boundaries of the 
discipline to create new rendezvous points and theoretical insights (e.g. Zedner, 2007; Hall and Winlow, 
2015). An alternative position – and one that perhaps best resembles the mainstream of what public 
criminology entails - is where academics cross the policy threshold, taking up roles within government 
or other state agencies (e.g. Stanko, 2007). It is with this latter position that Loader and Sparks (2011) 
have developed their understanding of public criminology. For Loader and Sparks (2011), the charged 
atmosphere in which criminal-justice policy discussions take place has led to a concomitant ‘heating up’ 
of the relationship between science and policy over the past few decades adding to the combustible 
policy context of successful failure. This does, however, present an opportunity for scholars. Under such 
conditions, key actors can add ‘coolant’ to the debate mainly by engaging in traditional scholarship: 
these include scientific experts, policy advisors and the observer-turned-players, but by contrast some 
add further heat mainly through organic means: the social movement theorist/activist and the lonely 
prophet. Table 1 considers the different modes of scholarly engagement in the criminal justice policy 
process.  
 
Table 1: Typology of modes of criminological engagement (adopted from Loader and Sparks, 2011) 
Types Description 
Scientific expert The scientific expert focuses on the production and 
dissemination of scientific knowledge and does not go 
beyond infrequent participation in formal advisory 
structures. The scientific expert uses knowledge and 
methodological skills to answer questions of policy-
makers in a nuanced and well-considered way.  
Policy advisor The policy advisor does a great part of their research on 
(short-term) contracts for the government, and 
perceives it as a responsibility to bring scientific 
knowledge to policy-makers through formal advisory 
structures or even informal contacts (behind the public 
scenes) 
Observer-turned player The observer-turned player takes up the opportunity to 
participate directly to the development of policy (e.g. as 
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a representative of a Minister). This type is colloquially 
described as an expert who is getting his or her hands 
‘dirty’. 
Social movement 
theorist 
The social movement theorist colloquially supports a 
critical/alternative discourse placing knowledge and 
skills at the service of those who are marginalised. This 
type does not go beyond infrequent participation in 
formal advisory structures. 
Lonely prophet The lonely prophet focuses on theoretical engagement 
and the big picture while philosophising about social 
changes and movements. This type also does not go 
beyond infrequent participation in formal advisory 
structures. 
 
In the typology, positions range from a stance of near complete detachment to positions where one is 
more firmly involved in the policy apparatus (Deflem, 2005; Chancer and McLaughlin, 2007; Currie, 
2007; De Haan, 2008; Carrabine, et al., 2009; Rock, 2014). Loader and Sparks’ account of how 
criminologists understand their craft and position themselves in relation to social and political 
controversies about crime, has already prompted significant critique (Wacquant, 2011; Daems, 2011; 
Hammersley, 2013). For instance, Wacquant (2011) notes how these actor-centred perspectives afford 
little acknowledgement of the structural conditions under which scholarship is produced; that of the 
neo-liberal university which champions certain kinds of evidence over others and tends to silence the 
critical discourse of neoliberalism. It is also argued that their account lacks a substantial reflection on 
the evidence criminologists may bring into the policy process as academics also often seem to rely on 
extra-scientific means of persuasion which can jeopardise their credibility (Daems, 2011). 
Here we pursue an alternative critique putting Loader and Sparks typology to the empirical test to 
ascertain whether the roles outlined are indeed indicative of those taken by scholars engaging with the 
policy process. In doing so, we suggest that the typology is incomplete and that to be able to fully 
comprehend the role of scholarship in policy it is necessary to not only consider what different forms it 
might take, but also to consider how it happens. In doing so, we offer an evaluation the typology 
developed by Loader and Sparks by drawing on lessons from political science and the literature of 
research utilisation and considering the role of evidence and expertise in recent Belgian drug policy 
developments.  
 
Models of research utilisation: the role and nature of evidence use 
The long-established literature on research utilisation highlights the complex and often difficult nature 
of the relationship between evidence and policy in that evidence can influence policy, but only in certain 
ways and under specific circumstances (Laswell, 1951; Caplan, 1979; Weiss, 1979). One hypothesis is 
the idea of a direct link from evidence to policy which is often presented in the references to ‘evidence-
based policy’. Another is the view, described as the conceptual or enlightenment model, that evidence 
can influence policy indirectly by altering the language and perception of policy-makers. Yet the third 
hypothesis suggests that research utilisation may involve issues of political power (such as 
political/selective use of scientific knowledge). Table 2 considers these different models of research 
utilisation. 
 
Table 2: Three-folded typology of research utilisation (adopted from Weiss, 1979) 
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Three-folded typology  Description 
Instrumental  This model represents the typical 
understanding, a rather static approach, of the 
science-policy nexus. It assumes that scientific 
knowledge has a direct bearing on policy. 
Enlightenment / 
conceptual 
A dynamic perspective of the science-policy 
nexus is supported in this model. Scientific 
knowledge can be conceived as part of the 
process of policy-making. Utilisation must be 
considered as a series of events or processes 
which may (not) lead to a specific 
action/decision 
Political/symbolic  Offering a more strategic approach of research 
utilisation, in this model, scientific knowledge is 
considered as ammunition for political sides. It 
can be used to silence the arguments of the 
opposition or to support ideas, which the 
policy-makers have already adopted.  
 
The particular circumstances under which these research utilisation processes may, or may not, occur 
have been prominent in recent drug policy discussions (Lenton, 2007; Ritter, 2009; Monaghan 2011; 
2014 Stevens, 2011; Tieberghien, 2016). These studies show how establishing networks and active 
(recurrent) engagements with key players inside and outside the policy-making process, as well as 
participating in fora or committees is central to policy influence. In effect, they demonstrate when and 
why evidence is used or not used. A point often downplayed in policy analysis (Haynes, et al., 2011). In 
doing so, they descend the ladder of abstraction to focus on the mechanisms by which influence can 
occur. It is at this level that they offer insights for public scholarship.  
 
The Case of Belgian Drugs Policy Making (1996-2003) 
The foundations of modern Belgian drug policy were laid down in the first half of the 1990s, although 
the drug issue entered the legislative framework with Belgian law criminalising certain drugs and drugs 
possession in 1921. In the mid- 1990s, a ‘window of opportunity’ (Kingdon, 2002) opened up when a 
Parliamentary Working group on drugs (1996-1997) was established by the Federal Parliament in order 
to develop a clear and timely view on all aspects of the Belgian drug phenomenon. The Parliamentary 
Working Group asked national and international experts, working in all domains of drug policy, to 
convey their analysis and to give clear recommendations to the Federal Government. After a silent 
intermezzo between 1997 and 2000, the drug issue re-emerged on the political agenda. The new 
Belgian Government further elaborated the principles and recommendations of the Parliamentary 
Working Group (1996-1997) and established the first ‘national drug strategy’ in 2001. The Federal Drug 
Policy Note (2001) determined the policy priorities and thus the legislative and prosecution framework. 
The strategy recommended developing an integrated and integral drug policy, officially replacing a 
purely criminal approach by a discourse where the drug problem was primarily considered a problem 
of public health (Federal Government, 2001). As one of the action points of the Federal Drug Policy 
Note (2001), the Federal Government planned to amend the Belgian Narcotic Drug Law of 1921 and, 
accordingly, to develop a new Ministerial Circular Letter. The new drug law and the new Ministerial 
Circular Letter were endorsed just before the 2003 elections. These decisions, together with the 
election of a new Government (Verhofstadt II Government: a four-party Government with only the 
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Flemish and French-speaking liberals and the Flemish and French-speaking socialists in power), marked 
the closing of the policy window. Both the 2001 drug strategy and the 2003 drug law form the 
foundations of the Belgian drug policy today.  
One of us conducted a (critical) discourse analysis of specially selected newspaper articles and policy 
documents and interviews with 55 key informants focusing on the years 1996-2003 of Belgian drug 
policy. Both data collection methods were used in conjunction with one another. The discourse analysis 
consisted of a detailed and systematic reading of 164 policy documents including formal, publicly 
available expressions of strategy and statements of intent made by the Federal Government, as well as 
parliamentary discussions. Media analysis examined a total number of 1,067 Belgian (including Flemish 
as well as Walloon) newspaper articles. In the case example, policy documents and newspaper articles 
were collected from online databases, first using general key words like ‘drugs’, ‘drug use’, ‘substance 
use’, but eventually refined keywords such as ‘drug policy’, ‘Parliamentary Working Group Drugs’, 
‘Federal Drug Policy Note’, and ‘drug/cannabis law reform’.  
In both cases, Fairclough’s (2003) methodological framework was employed. Proven to be useful for 
the analysis of policy and media documents, the central focus of the framework is on examining how 
texts draw upon, incorporate, (re)contextualise and dialogue with other texts (so-called 
‘intertextuality’). Analysis particularly focused on the textual elements that characterise (differences 
between) discourses, how key policy players are represented in the text and from which perspective, 
how scientific knowledge and particular scientists were represented, the relationship of scientific 
knowledge to other forms of information available, and how this was related to the various types of 
research utilisation and public scholarship. The work in collecting and analysing the policy and media 
documents was completed between July 2011 and October 2012. Discourse analysis is always a matter 
of interpretation, especially because it depends entirely on the cogency of a researcher’s arguments 
and/or bilingual abilities. Therefore, additionally, between January and December 2013 fifty-five semi-
structured interviews with policy-makers (33), scientists (6), journalists (6), professionals (6) and 
members of interest groups (4) were conducted to better understand the interactions between 
multiple actors, contextual developments, informal initiatives, networks, conflicts and strategies. Each 
of these key players was selected on the basis of their knowledge, experience and position within the 
case. The interview schedule covered key themes such as the respondent’s perception of their role in 
the policy process and particular position in the debate (related to research utilisation and/or policy 
development), their opinions about the roles played by scientific knowledge and scientists, 
ideological/political motives, media and interest groups in the parliamentary and governmental 
debates, and their general perception about the evidence-based/evidence-informed characteristics of 
the development of Belgian drug policy. Entering the worlds of those involved in the debate and 
engaging them in an interview is seen as an appropriate way to the understanding of the research 
utilisation and public scholarship process (Trostle, et al., 1999) and to understand techniques of 
engaging with policy. 
 
Understanding and Explaining the Role of Public Scholarship 
Within the ‘hot’ climate in which the development of Belgian drug policy development (1996-2003) 
unfolded, scientists performed a variety of public roles. Consistent with Loader and Sparks, we noted 
public engagements as scientific experts, policy advisors, observer-turned players, or social movement 
theorists/activists. Lonely prophets were notable for their absence, although when discussion concern 
specific policy matters rather than deeper ontological concerns this is not entirely unexpected. 
‘Cooling devices’: scientific experts, policy advisors and observer-turned players 
For some scientists, the most fruitful way to cultivate a rational policy approach is to emphasize 
scientific credibility and methodological rigour. Their public engagement is restricted to passively 
disseminating what they know alongside rare participation in formal advisory structures. In particular, 
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several scientific experts participated in the Parliamentary Working Group on drugs in 1996 and the 
Commission of Public Health (discussing the drug law reform) in 2002. In doing so, they carefully replied 
to questions for information but were not proactively seeking to engage outside these formal advisory 
structures (they considered this a ‘red line’ not to cross):  
“My contribution was for the most part illustrative, I gave some additional information. 
That’s it […] I was not searching for participation, I did not make an effort. I always try to 
formulate clear recommendations. Maybe this is not good enough and maybe I should 
participate in the policy-making process. The question is then, to what extent is your 
scientific research compromised or does one have the impression it is compromised?” 
(Respondent 24, scientist). 
“I just presented some facts, data and that is it […] They asked me as an expert. I do not 
take the initiative myself to get involved actively. That is not my goal as an academic.” 
(Respondent 13, scientist). 
Clearly, in this position most tensions remain between the public role and the academic position with 
often competing audiences and expectations. While this form of engagement entails minimal 
involvement in the policy-making process, those scientific experts have sought to influence the policy-
making process in a light touch way through the dissemination of data and interpretations. This is in 
accordance with the conceptual or ‘enlightenment’ model of research utilisation where scientific 
knowledge can be conceived as part of the process of policy-making (e.g. in the percolation of new 
ideas) (Weiss, 1979; Nutley, 2003). For instance, in the PWG (1996-1997), scientific experts stimulated 
thorough discussion and reflection among policy-makers, leading to the first steps in changing the 
policy discourse in Belgium. By repeatedly referring to the policy-funded study of De Ruyver, et al. 
(1992; Poverty, drug use and criminality) and the study of Vercaigne and Walgrave (1995; Youth 
between (sub)cultures and business: a study focusing on discotheques, house music and nuisance), the 
contributions of the so-called scientific experts served as strong scientific support for, respectively, the 
argument that (problematic) drug users in the criminal justice system had to be oriented more towards 
treatment, and the argument that prevention initiatives have to pay special attention to youth, smart 
drugs and the consequences of drug use for road safety. As a result, the report of the PWG and its 
bibliography provided a clear and careful integration of most of the good practices and 
recommendations. Likewise, although the parliamentary debate about the Belgian drug law in the 
Commission of Public Health (2002-2003) largely focused on juridical-technical issues, the contributions 
of several scientific experts sensitised MPs to ‘new’ scientific knowledge focusing on the dangers of 
cannabis (e.g. the increasing level of THC, the connection between cannabis use and psychiatric 
disorders). In offering strong support to arguments against the advocates of a liberal policy, the 
correlation between early and regular cannabis use and the risk of developing schizophrenia, 
depression or other psychotic disorders featured increasingly in many parliamentary discussions from 
2002-2003 onwards (Hand. Kamer 2001-2002, 21 februari 2002, 208, 32-33; Hand. Senaat 2001-2002, 
19 maart 2002, 2-51, 2692).  
While still keeping a firm distinction between scientific research and giving advice to policy-makers, 
policy advisors attach more importance to informing the policy-making process actively. In doing so, 
some scientists pointed at their public engagements in providing evidence to formal advisory 
structures, advising MPs or Ministers informally (e.g. through the attendance of study groups of political 
parties) and establishing contacts with professionals (e.g. police, outreach workers, …) in order to 
influence the policy-making process rather indirectly.  
“First, I tried to influence the highest level of the policy-making process but that was not 
successful. It is better to work bottom-up, talking with professionals and MPs in order to 
climb up. I also have found other ways to distribute information and get involved, I have 
attended a lot of conferences, participated in study groups, etc. That is the role of a 
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scientist. Of course, I understand that some scientists do not do this […] Eventually, I played 
a role” (Respondent 52, scientist). 
“A study group of a political party is totally different from participating in a formal advisory 
structure. For instance, in the PWG, an expert had less influence. Each scientist gives a 
presentation and answers questions. Taking part in a study group allows the expert 
participate in the development of a party policy on drug policy” (Respondent 47, scientist). 
Indicative of the importance attached to establishing good contacts with policy-makers and 
professionals, is the initiative from a policy advisor who picked up the growing need to develop a 
comprehensive national drug policy in Belgium. From 1993, an annual conference ‘Drug policy 2000’ 
was organised in order to develop and stimulate the interaction between practice, science and policy 
(De Ruyver, et al., 1995). During these national conferences several drug-related topics were discussed, 
clearly following the main interests of the media, professionals and policy-makers. The conference was 
attended by several actors (policy-makers, scientists, practitioners, journalists) which made it possible 
to stimulate debate about (different) ideas as well as cooperation between (Dutch-speaking and 
French-speaking) practitioners, scientists, policy-makers and journalists. These important and highly 
attended conferences set and kept this particular issue high on the political and public/media agenda.  
“Those conferences were the mecca of politicians, scientists and practitioners. It was a kind 
of movement of people who had finally found each other. The conferences also gave a lot 
of input to the debate in the Parliamentary Working Group on drugs as it can be considered 
as a sort of prolongation of these debates.” (Respondent 9, practitioner). 
Of course not all engagement is ‘public’. Much lobbying, discussion and persuasion takes place behind 
the stage, but this can be seen as a (successful) route to be known as experts in the particular field by 
policy-makers and to establish an interaction between science and policy. Policy advisors allowed for a 
flow of scientific information to the policy-making process. Not only the annual conferences indirectly 
encouraged a greater role of scientific knowledge in the policy-making process, but this type of 
engagement also resulted in policy advisors doing a large part of their research on (short-term) 
contracts for the Government, a type of research which appears to be particularly attractive to policy-
makers. For example, the policy-funded inventory of the drug research in Belgium and its neighbouring 
countries like the Netherlands, Great Britain and France (Van Daele, et al., 1996) was frequently 
mentioned in the PWG and was used to describe the percentages of cannabis and ecstasy use and drug-
related crimes in parliamentary questions or interpellations. As another example, due to his proactive 
and long-term involvement as policy advisor in the drug policy-making process (e.g. PWG or policy-
funded research), scientist Isidore Pelc was appointed President of the Drug Health Policy Cell, a 
supporting working cell of the General Drugs Policy Cell. In Belgium, it is the General Drugs Policy Cell 
who prepares the policy decisions of the Ministers involved in the field of drugs. As a result, in the 
development of the drug law reform (2003), the Drug Health Policy Cell discussed some preliminary 
policy documents (bill, Royal Decree, Cooperation agreement, etc.) and eventually formulated some 
advice which was inspired by scientific knowledge indirectly (Cel Gezondheidsbeleid Drugs, 2002, p.17).  
One scientist, Brice De Ruyver, considered it more useful to try to influence policy and secure greater 
influence for scientific knowledge from the ‘inside’. It has been put forward that most scientists often 
do not have any idea of how policy-making works or how to produce scientific knowledge that stands 
a chance of influencing policy-makers (Cairney, 2016). Only from the ‘inside’ scientists are able to 
discover how the process works and what exerts some influence. In this way, for Loader and Sparks, 
the scientist becomes an observer-turned player, 
“Many scientists do not have a good idea of how the policy-making process works or how 
scientific knowledge may have any influence […] Even those who are rarely engaged expect 
policy-makers to implement what they recommend. Wrong, you need to know how politics 
works” (Respondent 50, scientist). 
 9 
Several examples show how an observer-turned player took up the opportunity to participate directly 
to the development of Belgian drug policy and how successful this was in the light of research 
utilisation. First of all, scientist Brice De Ruyver adopted an active engagement in the parliamentary 
debates. In particular, as a consequence of his expertise and networks (due to the organisation of the 
national conferences ‘Drug Policy 2000’), he was appointed by the PWG as ‘external expert’ to integrate 
the findings from the expert hearings into a report and, secondly, to write a draft of the final conclusions 
and recommendations. In this sense, he acted as a kind of knowledge broker. This draft served as a 
starting point in the political discussion about Belgian drug policy among the members of the PWG. 
Altering the tone of the political discussion, the report produced a clear expression of the social and 
health discourse with the emergence of the harm reduction movement instead of a strict repressive 
discourse. However, simultaneously, the report already offered and tailored advice in accordance with 
the preferences of the policy-makers. Clearly, as the members of the PWG aimed to have a sufficient 
base for policy debate, the observer-turned player could not retain his autonomy/neutrality completely 
in writing the summarising report. As suggested by Loader and Sparks (2011), this type of public 
engagement can be described as a role where the expert is getting his or her hands ‘dirty’, addressing 
the very thin line between being neutral/external expert or a policy-advocating expert.  
Second, the evidence-based policy discourse and movement, despite its criticisms, has given scientists 
a more overt and direct role in Belgian drug policy-making at the governmental level. In 1999, the 
Verhofstadt I Government underlined that scientific knowledge was an important resource in policy-
making. As a result, uniquely in the Belgian context, Brice De Ruyver became the security advisor to 
Prime Minister Guy Verhofstadt. It became clear that this type of public engagement meaningfully 
impacts upon and shapes policy. In particular, this role enabled the observer-turned player to promote 
the instrumental utilisation of his own scientific research and that of others in the political arena. The 
instrumental view assumes that scientific knowledge has a direct bearing on policy (Weiss, 1979; 
Nutley, 2003). As a clear example, the evaluation study ‘Belgian drug policy in the year 2000: state of 
the art 3 years after the recommendations of the PWG’ (De Ruyver, et al., 2000) inspired the Federal 
Drug Policy Note (Federal Government, 2001).  
“The report of the PWG and the evaluation study were used […] The Federal Drug Policy 
Note had to be in accordance with these documents […] We did not have to start ‘from 
scratch […] Working at the governmental level is special: the aim is to unite the 
representatives of the Ministers and to decide’’ (Respondent 50, scientist). 
On the one hand, the second part of the Federal Drug Policy Note (p.14-31) described the main 
conclusions of the evaluation study conducted by De Ruyver and colleagues (De Ruyver, et al., 2000). 
This detailed the actual state of the drug problem and capturing recommendations of the PWG that 
had already been implemented by the time the policy was created. On the other hand, the 
recommendations of the evaluation study were influential in determining the specific policy actions by 
the Federal Government (third part Federal Drug Policy Note, p.31-68). For instance, the evaluation 
report stressed that, in order to finally realise an integral and integrated drug policy with a vertical and 
a horizontal policy coordination, “the establishment of a General Drugs Policy Cell must be considered 
as necessary and crucial” (De Ruyver, et al., 2000, p.8). Accordingly, the establishment of a General 
Drugs Policy Cell was one of the most important action points of the Federal Drug Policy Note in 
pursuing a global and integrated approach (Federal Government, 2001a, p.31). As a second example, 
inspired by the particular recommendations of the evaluation study regarding the problem of driving 
under the influence of illegal drugs and medication (De Ruyver, et al., 2000, p.13-15, 23), the Federal 
Drug Policy Note included a number of actions (e.g. prevention campaigns, implementation of drug 
tests, etc.) (Federal Government, 2001a, p.43). Also the persistent concern about the lack of reliable 
numbers or registrations and the lack of (funding for) epidemiological studies on drug use was re-
emphasised in the evaluation study (De Ruyver, et al., 2000, p.20-21). In the Federal Drug Policy Note, 
the Federal Government eventually demonstrated commitment and responsiveness: e.g. by means of 
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establishing a research programme supporting decision-making in the field of illegal drugs (Federal 
Government, 2001a, p.37-41). 
In a similar vein, Brice De Ruyver promoted the instrumental utilisation of other (international) scientific 
research. Taking into account that policy-makers are also responsible for the international aspects of 
their policy competences, several national and international drug policy studies (with special attention 
to the cannabis policy) were compared (Federal Government, 2001, p.57-58). As a result, the analysis 
of drug policies in other European countries (the Netherlands, France, Germany, Luxembourg, the 
United Kingdom), included in the attachment of the Federal Drug Policy Note, was very much a result 
of the promotion by this observer-turned player, as outlined by policy personnel involved at the time:  
“I remember that we took into account some international studies of drug policies in 
European countries and the prevalence rates provided by the EMCDDA. Brice De Ruyver 
joined the Inter-Cabinet Working Group to stimulate the debate. He also urged more 
scientific support.” (Respondent 20, policy-maker). 
“A permanent dialogue with Brice De Ruyver was used to advance the debate regarding 
the Federal Drug Policy Note. In particular, he kept close contacts with the policy-makers. 
He had a very large political network. As a policy-maker, I talked with him in order to get a 
scientific update.” (Respondent 34, policy-maker). 
With this in mind, such a public role seems by far the most effective means to advance an evidence-
informed drug policy. However, it is important to set realistic expectations about the contributions of 
scientists in the policy-making process. An observer-turned player is able to inform policy-making, not 
to make it. Some findings of the evaluation study and international drug policy studies were also used 
in a more political/symbolic way by policy-makers. In the political/symbolic model of research 
utilisation, scientific knowledge is considered as ammunition for political sides (Weiss, 1979). For 
instance, an important recommendation was that the Federal Drug Policy Note had to resolve the lack 
of uniformity in prosecutions of cannabis possession between different Public Prosecutor’s offices. The 
evaluation study attributed a large part of this problem to rather vague notions such as ‘public 
nuisance’, ‘problematic use’ and ‘limited possession for personal (single or occasional) use’ (De Ruyver, 
et al., 2000, p.41). However, there were important shortcomings in the efforts to address this 
deficiency. Although the Federal Drug Policy Note introduced new definitions, they still remained too 
blurry and open to interpretation by police officers, prevention workers, social workers and the general 
public. In other words, in the Federal Drug Policy Note reference was made to the Governments’ 
investment in the research, by way of demonstrating commitment and responsiveness. Nevertheless, 
the vagueness of these notions was not resolved. 
Mobilisation of ‘heating’ alternatives by social movement theorists 
According to Loader and Sparks (2011), social movement theorists/activists take up a similar role as 
scientific experts as they primarily aim to produce scientific knowledge and do not go beyond 
infrequent participation in formal advisory structures. However, they seek to influence in a different 
manner by acting as a ‘heating device’ and injecting critical/alternative discourse into debates. Social 
movement theorists/activists align themselves with social groups whose interests are not served by 
policy-makers and aim to place knowledge and skills at the service of those who are marginalised or 
excluded (e.g. drug users).  
“As scientists, we have to engage in the movement for the reduction of the harm for drug 
users by critically addressing the existing presuppositions about drugs in society […] For 
instance, most community based drug use is highly ‘controlled’ […] and associated with low 
risk for the large majority of drug users […] these insights are relevant for policy-makers 
who are looking for alternatives (Peter Cohen, scientist; Report of the PWG, p.172-185). 
In the PWG, issues concerning the largely unproblematic characteristic of drug use, the role of self-
control strategies and the legitimacy of the criminalisation of drugs (cannabis in particular) have been 
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put forward by several scientists. Those struggle for alternative politics were, however, not successful 
in impacting upon research utilisation in policy-making. Their insights were used as ammunition in 
political struggles among MPs (political/symbolic utilisation) but tended to be left unused in actual 
policy-making. In other words, even though their knowledge was embedded in the policy process, too 
radical accounts were likely to be excluded (Stevens, 2007). As advocated by Walters (2003), it is clear 
that some scientific knowledge fits the interests of the powerful groups, while others may not. The 
choice of what counts as ‘usable’ scientific knowledge and who is considered authoritative or 
trustworthy involves acts of power. 
“Scientific research is not always usable for policy-makers. For instance, there were some 
critical voices […] if there are too many differences in opinion with the leading policy-
makers, it is difficult to play a role.” (Respondent 5, policy-maker). 
“It makes no sense to integrate findings that are supporting a totally different view than 
the view policy-makers want to end with […] some critical issues indeed have been left out 
in the final report” (Respondent 4, policy-maker). 
Nevertheless, it became clear that social movement theorists/activists can mobilise alternative avenues 
for the uptake of scientific knowledge. While heating up the political climate, these alternative voices 
also generated a large public response: a considerable number of newspaper articles covered these 
accounts and, simultaneously, several interest groups, campaigning for drug user’s rights, were 
vigorous in promoting these ideas and persuading policy-makers through the media and through the 
organisation of demonstrations. The creation of a powerful counter discourse eventually resulted in 
the Federal Drug Policy Note (2001) stating that “the Federal Government is an advocate of the need 
to rethink the international conventions in order to produce a realistic response to cannabis use as well 
as the establishment of harm reduction initiatives” (p.46, Federal Drug Policy Note). This can be 
considered an important element of the reframing of Belgian drug policy and one that several 
stakeholders such as social movement theorists/activists, media and interest groups (with the help of 
the green parties) had fought to bring about since the PWG.  
Discussion 
A focus on the individual actions and capacities of key actors – as put forward by the framework of 
Loader and Sparks (2011) - is interesting, not least because it informs us about the ways in which 
scholars can put their body of knowledge to the service of policy-makers alongside other legitimate 
forms of interests or knowledge. They offer neat and accurate descriptions of the different forms of 
engagement. However, these stories are incomplete. By drawing on the research utilisation literature, 
in particular, that which shows how the evidence and policy connection occurs we are able to see how 
the journey from evidence to policy takes place. In this sense, the longer-established research utilisation 
literature is useful to obtain a better understanding of the success or impact of public engagement 
within the framework of the complex power structures that exist in policy development (e.g. Weiss, 
1979, Nutley, et al., 2007; Ingold and Monaghan, 2016; MacGregor, et al., 2014).  
Drawing on the work of Weiss (1979) and Nutley (2003) we demarcate three main types of research 
utilisation that cover the direct to indirect scale. While acknowledging that the categories used are less 
straightforward than they have been portrayed, the influence of the public roles on research utilisation 
weighted differently and depended on the type of engagement, and the phase of policy development 
in which they were engaged. The public engagement of scientists in the run up to the Parliamentary 
Working Group was characterised by awareness raising of ideas and research by scientists embroiled 
in the process. Scientists described their input as ‘giving information’ and presenting ‘facts’ and ‘data’. 
Here there was a suggestion that they did not engage further, but that they as scientists performed an 
enlightenment function by trying to insert evidence and data into political decision-making. In a similar 
vein, during the establishment of the national conferences on drug use which brought together 
scientists, policy makers and other key stakeholders, the impetus was to foster cooperation and the 
increasing flow of scientific information into the process rather than the outcomes of policy. Again this 
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has the hallmarks of the enlightenment and/or conceptual role of evidence in policy. At times where 
scientists became more involved in the process, there was a shift in the kinds of influence they sought 
to achieve. The case of Brice De Ruyver is illustrative here. De Ruyver’s role in Belgian policy oscillated 
over the period in question. As the deliberations of the PWG progressed, De Ruyver was co-opted as 
an external expert to integrate scientific findings into the policy document. At this point there is a subtle 
shift from conceptual influence to a more direct influence in policy formulation. But this is not as an 
independent voice. It is more to add scientific weight to a pre-established direction of travel. Here we 
witness a more political/tactical use of evidence. However, when we consider the role of De Ruyver in 
the development of the Drug Policy Note, his influence shifts to more instrumental use whereby De 
Ruyver is described by policy makers as ‘stimulating debate’ by making sure that politicians and 
decision-makers took into account ‘international studies of drug policies in European countries’. Thus, 
via central, influential positions within parliament and government, he created a heightened role for 
evidence in the policymaking process and mobilised more open and better informed debate. Of course 
proximity to decision-making is not the determinant of kinds of influence in the form of evidence used 
by scientists. Critics of policy involved in ‘heating up’ debates similarly employed conceptual uses of 
evidence to try and shape the debate. This can be seen in attempts by scientists to raise the contentious 
issue of harm reduction in debates concerning the PWG, which although high-profile, had little impact 
on the overall policy.  
Second, the examples above also demonstrate how the use of evidence is a multifaceted process that 
involves multiple steps and multiple actors operating within a wider political context, rather than simple 
interaction between single key actors. The example of the observer-turned player Brice De Ruyver 
illustrates this account most clearly. While he succeeded in adding some ‘coolant’ to the heated debate, 
the ‘success’ of his public engagement was contingent on the rules of politics and competition. After 
all, even an observer-turned player, who devotes themselves to problem representation or the 
introduction of acceptable, feasible alternatives, will only stand a chance of influencing policy when the 
evidence fits with a pre-established stance and if it has engaged sponsors in policy circles. Evidence use 
rarely occurs in a linear/instrumental way and is not a product derived exclusively from the scholar’s 
skills or actions to take advantage of the ‘windows of opportunity’ and heightened levels of attention 
to policy problems. Policy change or development is driven by a plurality of factors, especially when 
considering moments of incremental changes. Thus, an emphasis on public scholarship in relation to 
evidence use is a way to obtain a greater understanding of the place of public criminology in the array 
of orientations within the profession. The political context makes the practice of public criminology not 
only difficult but also important. Public engagement can cool the climate by producing creditable 
evidence about what works and what does not. A thorough understanding of the complexity of the 
problem is an essential element for an improved policy.  
 
Concluding Remarks 
Public engagement, from a criminological perspective, is not only a debate about whether (social) 
scientists should try to engage a broader non-academic audience, but why and how scientific 
knowledge can make effective and intelligible contributions in the policy-making process given the ‘hot’ 
climate in which it operates. Loader and Sparks (2011) have developed a typology to illustrate the ways 
in which engagement can occur. We conclude that it forms a useful part of the explanatory canon. We 
think, however, that the complexities of the policy process and the role of evidence cannot be explained 
solely from actor-centric typologies. Synthesising lessons drawn from the research utilisation literature 
with the work of public criminology provide a potential way forward. In this sense, we have sought to 
situate the actor within the network of policy-making. The case of Belgian drugs policy offers a useful 
reminder of the challenges and opportunities of public engagement in what is at bottom an ineluctably 
political process. Irrespective of the veracity of scientific facts they publish, statements or results that 
are considered inconsistent or unacceptable are always susceptible to the abasement of those in 
power.  
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The few comparative studies in this field have shown that, in a variety of socio-economic, cultural and 
political environments, countries may strongly differ in how they do, or do not, value and use scientific 
research in formulating or shaping policy (Nutley, et al., 2010; Ritter, et al., 2016). Thus, the dynamics 
of the policy-making processes as well as the roles of the different actors may change over time, across 
situations, interests and issues. While caution is needed in making generalisations, our narrative 
provides a platform for future (empirical) considerations on whether and how public engagement 
meaningfully impacts upon and shapes research utilisation in policy-making in other countries or other 
(heavily politicised) policy areas. 
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